Tumoral MGMT content predicts survival in patients with aggressive pituitary tumors and pituitary carcinomas given treatment with temozolomide

2018

Additional Metadata
Persistent URL	doi.org/10.1007/s12020-018-1751-9, hdl.handle.net/1765/110486
Journal	Endocrine : International Journal of Basic and Clinical Endocrinology
Citation APA Style AAA Style APA Style Cell Style Chicago Style Harvard Style IEEE Style MLA Style Nature Style Vancouver Style American-Institute-of-Physics Style Council-of-Science-Editors Style BibTex Format Endnote Format RIS Format CSL Format DOIs only Format	Bengtsson, D. (D.), Schrøder, H.D. (H. D.), Berinder, K, Maiter, D, Hoÿbye, C, Ragnarsson, O, … Burman, P. (2018). Tumoral MGMT content predicts survival in patients with aggressive pituitary tumors and pituitary carcinomas given treatment with temozolomide. Endocrine : International Journal of Basic and Clinical Endocrinology. doi:10.1007/s12020-018-1751-9

Publication